361 Capital’s Veracyte VCYT Stock Holding History

361 Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100,307	Closed	-$2.86M	–	381
2019 Q2	$2.86M	Sell	100,307 -6,973	-6%	-$174K	0.51%	47
2019 Q1	$2.68M	Buy	+107,280	New	+$2.05M	0.47%	99

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

361 Capital's VCYT Position: Q3 2019 in Review

361 Capital sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 100,307 shares — an estimated $2.86M sold.

361 Capital first reported a position in VCYT in Q1 2019 and held it in 2 quarters. The position peaked at $2.86M in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

361 Capital reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
361 Capital sold 100,307 Veracyte shares in Q3 2019, an estimated $2.86M.
361 Capital first reported a position in Veracyte in Q1 2019 and held it in 2 quarters.
361 Capital's Veracyte position peaked at $2.86M in Q2 2019.
187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on 361 Capital's 13F filing for Q3 2019, filed 14 Nov 2019.